Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 548

    1.

    Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism.

    Tschritter O, Fritsche A, Thamer C, Haap M, Shirkavand F, Rahe S, Staiger H, Maerker E, Häring H, Stumvoll M.

    Diabetes. 2003 Feb;52(2):239-43.PMID: 12540592 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans.

    Stefan N, Vozarova B, Funahashi T, Matsuzawa Y, Weyer C, Lindsay RS, Youngren JF, Havel PJ, Pratley RE, Bogardus C, Tataranni PA.

    Diabetes. 2002 Jun;51(6):1884-8.PMID: 12031977 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome.

    Ducluzeau PH, Cousin P, Malvoisin E, Bornet H, Vidal H, Laville M, Pugeat M.

    J Clin Endocrinol Metab. 2003 Aug;88(8):3626-31.PMID: 12915646 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia.

    Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA.

    J Clin Endocrinol Metab. 2001 May;86(5):1930-5.PMID: 11344187 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patients.

    Miyazaki Y, Mahankali A, Wajcberg E, Bajaj M, Mandarino LJ, DeFronzo RA.

    J Clin Endocrinol Metab. 2004 Sep;89(9):4312-9.PMID: 15356026 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Sustained reduction in plasma free fatty acid concentration improves insulin action without altering plasma adipocytokine levels in subjects with strong family history of type 2 diabetes.

    Bajaj M, Suraamornkul S, Kashyap S, Cusi K, Mandarino L, DeFronzo RA.

    J Clin Endocrinol Metab. 2004 Sep;89(9):4649-55.PMID: 15356076 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Plasma adiponectin and leptin levels, body composition, and glucose utilization in adult women with wide ranges of age and obesity.

    Ryan AS, Berman DM, Nicklas BJ, Sinha M, Gingerich RL, Meneilly GS, Egan JM, Elahi D.

    Diabetes Care. 2003 Aug;26(8):2383-8.PMID: 12882866 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Adiponectin relationship with lipid metabolism is independent of body fat mass: evidence from both cross-sectional and intervention studies.

    Baratta R, Amato S, Degano C, Farina MG, Patanè G, Vigneri R, Frittitta L.

    J Clin Endocrinol Metab. 2004 Jun;89(6):2665-71.PMID: 15181039 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients.

    Bajaj M, Suraamornkul S, Piper P, Hardies LJ, Glass L, Cersosimo E, Pratipanawatr T, Miyazaki Y, DeFronzo RA.

    J Clin Endocrinol Metab. 2004 Jan;89(1):200-6.PMID: 14715850 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects.

    Yu JG, Javorschi S, Hevener AL, Kruszynska YT, Norman RA, Sinha M, Olefsky JM.

    Diabetes. 2002 Oct;51(10):2968-74.PMID: 12351435 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Plasma adiponectin levels are not associated with fat oxidation in humans.

    Stefan N, Vozarova B, Funahashi T, Matsuzawa Y, Ravussin E, Weyer C, Tataranni PA.

    Obes Res. 2002 Oct;10(10):1016-20.PMID: 12376582 [PubMed - indexed for MEDLINE]Related articles

    12.

    Elevated serum GGT concentrations predict reduced insulin sensitivity and increased intrahepatic lipids.

    Thamer C, Tschritter O, Haap M, Shirkavand F, Machann J, Fritsche A, Schick F, Häring H, Stumvoll M.

    Horm Metab Res. 2005 Apr;37(4):246-51.PMID: 15952086 [PubMed - indexed for MEDLINE]Related articles

    13.

    Adiponectin in a native Canadian population experiencing rapid epidemiological transition.

    Hanley AJ, Connelly PW, Harris SB, Zinman B.

    Diabetes Care. 2003 Dec;26(12):3219-25.PMID: 14633805 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Plasma adiponectin and endogenous glucose production in humans.

    Stefan N, Stumvoll M, Vozarova B, Weyer C, Funahashi T, Matsuzawa Y, Bogardus C, Tataranni PA.

    Diabetes Care. 2003 Dec;26(12):3315-9.PMID: 14633820 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Serum adiponectin as a biomarker for in vivo PPARgamma activation and PPARgamma agonist-induced efficacy on insulin sensitization/lipid lowering in rats.

    Yang B, Brown KK, Chen L, Carrick KM, Clifton LG, McNulty JA, Winegar DA, Strum JC, Stimpson SA, Pahel GL.

    BMC Pharmacol. 2004 Oct 18;4:23.PMID: 15491498 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    [White blood cell count as a predictor of glucose tolerance and insulin sensitivity. The role of inflammation in the pathogenesis of type 2 diabetes mellitus]

    Fritsche A, Häring H, Stumvoll M.

    Dtsch Med Wochenschr. 2004 Feb 6;129(6):244-8. German. PMID: 14750050 [PubMed - indexed for MEDLINE]Related articles

    17.

    Plasma adiponectin, insulin sensitivity, and subclinical inflammation in women with prior gestational diabetes mellitus.

    Winzer C, Wagner O, Festa A, Schneider B, Roden M, Bancher-Todesca D, Pacini G, Funahashi T, Kautzky-Willer A.

    Diabetes Care. 2004 Jul;27(7):1721-7.PMID: 15220253 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Relationship of hepatic and peripheral insulin resistance with plasminogen activator inhibitor-1 in Pima Indians.

    Nagi DK, Tracy R, Pratley R.

    Metabolism. 1996 Oct;45(10):1243-7.PMID: 8843179 [PubMed - indexed for MEDLINE]Related articles

    19.

    Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity.

    Bugianesi E, Pagotto U, Manini R, Vanni E, Gastaldelli A, de Iasio R, Gentilcore E, Natale S, Cassader M, Rizzetto M, Pasquali R, Marchesini G.

    J Clin Endocrinol Metab. 2005 Jun;90(6):3498-504. Epub 2005 Mar 29.PMID: 15797948 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Adiponectin in youth: relationship to visceral adiposity, insulin sensitivity, and beta-cell function.

    Bacha F, Saad R, Gungor N, Arslanian SA.

    Diabetes Care. 2004 Feb;27(2):547-52.PMID: 14747242 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data